🔎 Trials Near Me

Beranda › Neuroblastoma › Maryland

Uji klinis Neuroblastoma di Maryland

8 studi untuk Neuroblastoma mencari peserta di lokasi di Maryland.

Kota di Maryland

Teks studi resmi (Bahasa Inggris)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • University of Maryland/Greenebaum Cancer Center, Baltimore
  • Sinai Hospital of Baltimore, Baltimore
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
  • dan 1 lainnya
Menerima pesertaFase 3
Hingga usia 30 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06172296

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

  • National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
4 Weeks · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT01109394

Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma

  • National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 1
Usia 3 hingga 35 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06995872

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

  • National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasional
Usia 4 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT01005654

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • University of Maryland/Greenebaum Cancer Center, Baltimore
  • Sinai Hospital of Baltimore, Baltimore
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Menerima pesertaFase 3
365 Days – 30 Years · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT03126916

SPEARHEAD-3 Pediatric Study

  • National Institutes of Health, Bethesda
Menerima pesertaFase 1/2
Usia 2 hingga 21 · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT05642455

A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

  • National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 1
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 15 Jun 2026 · NCT06041516

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Menerima pesertaFase 2
Usia 1 hingga 50 · Semua jenis kelamin · Diperbarui 13 Mar 2026 · NCT01804634

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.